GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Capex-to-Operating-Income
中文

Changmao Biochemical Engineering Co (HKSE:00954) Capex-to-Operating-Income

: 10.01 (As of Jun. 2023)
View and export this data going back to 2002. Start your Free Trial

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Changmao Biochemical Engineering Co's Capital Expenditure for the six months ended in Jun. 2023 was HK$-80.01 Mil. Its Operating Income for the six months ended in Jun. 2023 was HK$8.00 Mil.

Hence, Changmao Biochemical Engineering Co's Capex-to-Operating-Income for the six months ended in Jun. 2023 was 10.01.


Changmao Biochemical Engineering Co Capex-to-Operating-Income Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 3.78 - 2.56 -

Changmao Biochemical Engineering Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.54 2.57 10.01 -

Competitive Comparison

For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changmao Biochemical Engineering Co Capex-to-Operating-Income Distribution

For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Changmao Biochemical Engineering Co's Capex-to-Operating-Income falls into.



Changmao Biochemical Engineering Co Capex-to-Operating-Income Calculation

Changmao Biochemical Engineering Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-249.607) / 97.688
=2.56

Changmao Biochemical Engineering Co's Capex-to-Operating-Income for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-80.009) / 7.997
=10.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changmao Biochemical Engineering Co  (HKSE:00954) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Changmao Biochemical Engineering Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Traded in Other Exchanges
N/A
Address
No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines